Graves' disease and hyperthyroidism trials in Australia

4 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

  Where

  Box Hill, Brisbane, Douglas, Geelong, Parkville, Perth, Saint Leonards, Southport, Sydney, Warrawong

  Age

  18 years to 75 years

  People

  210 worldwide

  Run by

  Immunovant Sciences GmbH

  See details and how to joinNCT07018323 · EU 2025-521920-31-00
• Phase 2Taking people
  Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease

  Where

  East Melbourne, Melbourne N., St Leonards

  Age

  18 years and over

  People

  232 worldwide

  Run by

  Yarrow Bioscience, Inc.

  See details and how to joinNCT07682896
• Phase 2Enrolling by invitation
  A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)

  Where

  Perth, South Brisbane, Southport, St Leonards, Sydney

  Age

  18 years and over

  People

  372 worldwide

  Run by

  Immunovant Sciences GmbH

  See details and how to joinNCT07286006
• Phase 1Taking people
  Study of BHV-1300 in Graves' Disease

  Where

  Fitzroy, Herston, Kotara, Melbourne, Oaklands Park, Parkville, St Leonards, Torquay

  Age

  18 years to 65 years

  People

  15 worldwide

  Run by

  Biohaven Therapeutics Ltd.

  See details and how to joinNCT06980649